FEATURED COMPANIES
- Bio-Rad Laboratories
- F. Hoffmann-La Roche Ltd.
- Luminex Corporation
- Merck KGaA
- Microsynth AG
- QIAGEN
Multiplex Detection Immunoassays Market - Scope of the Report
The publisher's report on the global multiplex detection immunoassays market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global multiplex detection immunoassays market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global multiplex detection immunoassays market during the forecast period.
The report has been prepared after extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ literature, annual reports, press releases, and relevant documents to understand the global multiplex detection immunoassays market.
Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global multiplex detection immunoassays market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global multiplex detection immunoassays market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global multiplex detection immunoassays market.
The report delves into the competitive landscape of the global multiplex detection immunoassays market. Key players operating in the global multiplex detection immunoassays market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global multiplex detection immunoassays market that have been profiled in this report.
Key Questions Answered in Multiplex Detection Immunoassays Market Report
A unique research methodology has been utilized to conduct comprehensive research on the growth of the global multiplex detection immunoassays market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
The primary sources referred to by analysts in the making of global multiplex detection immunoassays market report are salespersons of various companies. Secondary sources referred to by analysts for the global multiplex detection immunoassays market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the study on the global multiplex detection immunoassays market.
These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from multiplex detection immunoassays market leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global multiplex detection immunoassays market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in reaching the publisher's estimates on future prospects of the global multiplex detection immunoassays market more reliably and accurately.
The publisher's report on the global multiplex detection immunoassays market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global multiplex detection immunoassays market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global multiplex detection immunoassays market during the forecast period.
The report has been prepared after extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ literature, annual reports, press releases, and relevant documents to understand the global multiplex detection immunoassays market.
Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global multiplex detection immunoassays market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global multiplex detection immunoassays market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global multiplex detection immunoassays market.
The report delves into the competitive landscape of the global multiplex detection immunoassays market. Key players operating in the global multiplex detection immunoassays market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global multiplex detection immunoassays market that have been profiled in this report.
Key Questions Answered in Multiplex Detection Immunoassays Market Report
- What is the scope of growth of companies in the multiplex detection immunoassays market?
- What will be the Y-o-Y growth of the global multiplex detection immunoassays market between 2019 and 2027?
- What is the influence of changing trends in technologies on the global multiplex detection immunoassays market?
- Will North America continue to be the most profitable market for global multiplex detection immunoassays providers?
- Which factors will hamper the growth of the global multiplex detection immunoassays market during the forecast period?
- Which are the leading companies in the global multiplex detection immunoassays market?
A unique research methodology has been utilized to conduct comprehensive research on the growth of the global multiplex detection immunoassays market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
The primary sources referred to by analysts in the making of global multiplex detection immunoassays market report are salespersons of various companies. Secondary sources referred to by analysts for the global multiplex detection immunoassays market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the study on the global multiplex detection immunoassays market.
These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from multiplex detection immunoassays market leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global multiplex detection immunoassays market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in reaching the publisher's estimates on future prospects of the global multiplex detection immunoassays market more reliably and accurately.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Bio-Rad Laboratories
- F. Hoffmann-La Roche Ltd.
- Luminex Corporation
- Merck KGaA
- Microsynth AG
- QIAGEN
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Multiplex Detection Immunoassays Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Multiplex Detection Immunoassays Market Analysis and Forecast, 2018-2030
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Technological Advancement
5.2. Key Mergers & Acquisitions
5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Multiplex Detection Immunoassays Market Analysis and Forecast, by Assay Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Assay Type, 2018-2030
6.3.1. Planar Assays
6.3.1.1. Blends Protein Arrays (multiplexed ELISA)
6.3.1.2. Antibody Arrays
6.3.2. Bead-based Assays
6.3.2.1. Magnetic Bead-based
6.3.2.2. Non-magnetic Bead-based
6.4. Market Attractiveness Analysis, by Assay Type
7. Global Multiplex Detection Immunoassays Market Analysis and Forecasts, by Technique
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Technique, 2018-2030
7.3.1. Nucleic Acid-based Techniques
7.3.2. Protein-based Techniques
7.3.3. Biosensor-based Techniques
7.4. Market Attractiveness Analysis, by Technique
8. Global Multiplex Detection Immunoassays Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2018-2030
8.3.1. Disease Testing
8.3.1.1. Infectious Disease Testing
8.3.1.2. Autoimmune Disease Testing
8.3.1.3. Other Diseases Testing
8.3.2. Food Contamination Testing
8.3.3. Research & Development
8.3.4. Veterinary Disease Testing
8.4. Market Attractiveness Analysis, by Application
9. Global Multiplex Detection Immunoassays Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2018-2030
9.3.1. Pharmaceutical & Biopharmaceutical Companies
9.3.2. Clinical Research Organizations
9.3.3. Food & Beverage Industry
9.3.4. Academic & Research Institutes
9.3.5. Diagnostic Centers
9.3.6. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Multiplex Detection Immunoassays Market Analysis and Forecasts, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Country/Region
11. North America Multiplex Detection Immunoassays Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Assay Type, 2018-2030
11.2.1. Planar Assays
11.2.1.1. Blends Protein Arrays (multiplexed ELISA)
11.2.1.2. Antibody Arrays
11.2.2. Bead-based Assays
11.2.2.1. Magnetic Bead-based
11.2.2.2. Non-magnetic Bead-based
11.3. Market Value Forecast, by Technique, 2018-2030
11.3.1. Nucleic Acid-based Techniques
11.3.2. Protein-based Techniques
11.3.3. Biosensor-based Techniques
11.4. Market Value Forecast, by Application, 2018-2030
11.4.1. Disease Testing
11.4.1.1. Infectious Disease Testing
11.4.1.2. Autoimmune Disease Testing
11.4.1.3. Other Diseases Testing
11.4.2. Food Contamination Testing
11.4.3. Research & Development
11.4.4. Veterinary Disease Testing
11.5. Market Value Forecast, by End-user, 2018-2030
11.5.1. Pharmaceutical & Biopharmaceutical Companies
11.5.2. Clinical Research Organizations
11.5.3. Food & Beverage Industry
11.5.4. Academic & Research Institutes
11.5.5. Diagnostic Centers
11.5.6. Others
11.6. Market Value Forecast, by Country, 2018-2030
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Assay Type
11.7.2. By Technique
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Multiplex Detection Immunoassays Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Assay Type, 2018-2030
12.2.1. Planar Assays
12.2.1.1. Blends Protein Arrays (multiplexed ELISA)
12.2.1.2. Antibody Arrays
12.2.2. Bead-based Assays
12.2.2.1. Magnetic Bead-based
12.2.2.2. Non-magnetic Bead-based
12.3. Market Value Forecast, by Technique, 2018-2030
12.3.1. Nucleic Acid-based Techniques
12.3.2. Protein-based Techniques
12.3.3. Biosensor-based Techniques
12.4. Market Value Forecast, by Application, 2018-2030
12.4.1. Disease Testing
12.4.1.1. Infectious Disease Testing
12.4.1.2. Autoimmune Disease Testing
12.4.1.3. Other Diseases Testing
12.4.2. Food Contamination Testing
12.4.3. Research & Development
12.4.4. Veterinary Disease Testing
12.5. Market Value Forecast, by End-user, 2018-2030
12.5.1. Pharmaceutical & Biopharmaceutical Companies
12.5.2. Clinical Research Organizations
12.5.3. Food & Beverage Industry
12.5.4. Academic & Research Institutes
12.5.5. Diagnostic Centers
12.5.6. Others
12.6. Market Value Forecast, by Country/Sub-region, 2018-2030
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Assay Type
12.7.2. By Technique
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Multiplex Detection Immunoassays Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Assay Type, 2018-2030
13.2.1. Planar Assays
13.2.1.1. Blends Protein Arrays (multiplexed ELISA)
13.2.1.2. Antibody Arrays
13.2.2. Bead-based Assays
13.2.2.1. Magnetic Bead-based
13.2.2.2. Non-magnetic Bead-based
13.3. Market Value Forecast, by Technique, 2018-2030
13.3.1. Nucleic Acid-based Techniques
13.3.2. Protein-based Techniques
13.3.3. Biosensor-based Techniques
13.4. Market Value Forecast By Application, 2018-2030
13.4.1. Disease Testing
13.4.1.1. Infectious Disease Testing
13.4.1.2. Autoimmune Disease Testing
13.4.1.3. Other Diseases Testing
13.4.2. Food Contamination Testing
13.4.3. Research & Development
13.4.4. Veterinary Disease Testing
13.5. Market Value Forecast, by End-user, 2018-2030
13.5.1. Pharmaceutical & Biopharmaceutical Companies
13.5.2. Clinical Research Organizations
13.5.3. Food & Beverage Industry
13.5.4. Academic & Research Institutes
13.5.5. Diagnostic Centers
13.5.6. Others
13.6. Market Value Forecast, by Country/Sub-region, 2018-2030
13.6.1. China
13.6.2. India
13.6.3. Japan
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia pacific
13.7. Market Attractiveness Analysis
13.7.1. By Assay Type
13.7.2. By Technique
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Multiplex Detection Immunoassays Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Assay Type, 2018-2030
14.2.1. Planar Assays
14.2.1.1. Blends Protein Arrays (multiplexed ELISA)
14.2.1.2. Antibody Arrays
14.2.2. Bead-based Assays
14.2.2.1. Magnetic Bead-based
14.2.2.2. Non-magnetic Bead-based
14.3. Market Value Forecast, by Technique, 2018-2030
14.3.1. Nucleic Acid-based Techniques
14.3.2. Protein-based Techniques
14.3.3. Biosensor-based Techniques
14.4. Market Value Forecast, by Application, 2018-2030
14.4.1. Disease Testing
14.4.1.1. Infectious Disease Testing
14.4.1.2. Autoimmune Disease Testing
14.4.1.3. Other Diseases Testing
14.4.2. Food Contamination Testing
14.4.3. Research & Development
14.4.4. Veterinary Disease Testing
14.5. Market Value Forecast, by End-user, 2018-2030
14.5.1. Pharmaceutical & Biopharmaceutical Companies
14.5.2. Clinical Research Organizations
14.5.3. Food & Beverage Industry
14.5.4. Academic & Research Institutes
14.5.5. Diagnostic Centers
14.5.6. Others
14.6. Market Value Forecast, by Country/Sub-region, 2018-2030
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Assay Type
14.7.2. By Technique
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Multiplex Detection Immunoassays Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Assay Type, 2018-2030
15.2.1. Planar Assays
15.2.1.1. Blends Protein Arrays (multiplexed ELISA)
15.2.1.2. Antibody Arrays
15.2.2. Bead-based Assays
15.2.2.1. Magnetic Bead-based
15.2.2.2. Non-magnetic Bead-based
15.3. Market Value Forecast, by Technique, 2018-2030
15.3.1. Nucleic Acid-based Techniques
15.3.2. Protein-based Techniques
15.3.3. Biosensor-based Techniques
15.4. Market Value Forecast, by Application, 2018-2030
15.4.1. Disease Testing
15.4.1.1. Infectious Disease Testing
15.4.1.2. Autoimmune Disease Testing
15.4.1.3. Other Diseases Testing
15.4.2. Food Contamination Testing
15.4.3. Research & Development
15.4.4. Veterinary Disease Testing
15.5. Market Value Forecast, by End-user, 2018-2030
15.5.1. Pharmaceutical & Biopharmaceutical Companies
15.5.2. Clinical Research Organizations
15.5.3. Food & Beverage Industry
15.5.4. Academic & Research Institutes
15.5.5. Diagnostic Centers
15.5.6. Others
15.6. Market Value Forecast, by Country/Sub-region, 2018-2030
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Assay Type
15.7.2. By Technique
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company, 2018
16.3. Company Profiles
16.3.1. F. Hoffmann-La Roche Ltd.
16.3.1.1. Company Overview
16.3.1.2. Company Financials
16.3.1.3. Growth Strategies
16.3.1.4. SWOT Analysis
16.3.2. QIAGEN
16.3.2.1. Company Overview
16.3.2.2. Company Financials
16.3.2.3. Growth Strategies
16.3.2.4. SWOT Analysis
16.3.3. Merck KGaA
16.3.3.1. Company Overview
16.3.3.2. Company Financials
16.3.3.3. Growth Strategies
16.3.3.4. SWOT Analysis
16.3.4. Microsynth AG
16.3.4.1. Company Overview
16.3.4.2. Company Financials
16.3.4.3. Growth Strategies
16.3.4.4. SWOT Analysis
16.3.5. Bio-Rad Laboratories
16.3.5.1. Company Overview
16.3.5.2. Company Financials
16.3.5.3. Growth Strategies
16.3.5.4. SWOT Analysis
16.3.6. Thermo Fisher Scientific
16.3.6.1. Company Overview
16.3.6.2. Company Financials
16.3.6.3. Growth Strategies
16.3.6.4. SWOT Analysis
16.3.7. Luminex Corporation
16.3.7.1. Company Overview
16.3.7.2. Company Financials
16.3.7.3. Growth Strategies
16.3.7.4. SWOT Analysis
16.3.8. Becton, Dickinson and Company
16.3.8.1. Company Overview
16.3.8.2. Company Financials
16.3.8.3. Growth Strategies
16.3.8.4. SWOT Analysis
16.3.9. Other Prominent Key Players
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Multiplex Detection Immunoassays Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Multiplex Detection Immunoassays Market Analysis and Forecast, 2018-2030
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Technological Advancement
5.2. Key Mergers & Acquisitions
5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Multiplex Detection Immunoassays Market Analysis and Forecast, by Assay Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Assay Type, 2018-2030
6.3.1. Planar Assays
6.3.1.1. Blends Protein Arrays (multiplexed ELISA)
6.3.1.2. Antibody Arrays
6.3.2. Bead-based Assays
6.3.2.1. Magnetic Bead-based
6.3.2.2. Non-magnetic Bead-based
6.4. Market Attractiveness Analysis, by Assay Type
7. Global Multiplex Detection Immunoassays Market Analysis and Forecasts, by Technique
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Technique, 2018-2030
7.3.1. Nucleic Acid-based Techniques
7.3.2. Protein-based Techniques
7.3.3. Biosensor-based Techniques
7.4. Market Attractiveness Analysis, by Technique
8. Global Multiplex Detection Immunoassays Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2018-2030
8.3.1. Disease Testing
8.3.1.1. Infectious Disease Testing
8.3.1.2. Autoimmune Disease Testing
8.3.1.3. Other Diseases Testing
8.3.2. Food Contamination Testing
8.3.3. Research & Development
8.3.4. Veterinary Disease Testing
8.4. Market Attractiveness Analysis, by Application
9. Global Multiplex Detection Immunoassays Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2018-2030
9.3.1. Pharmaceutical & Biopharmaceutical Companies
9.3.2. Clinical Research Organizations
9.3.3. Food & Beverage Industry
9.3.4. Academic & Research Institutes
9.3.5. Diagnostic Centers
9.3.6. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Multiplex Detection Immunoassays Market Analysis and Forecasts, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Country/Region
11. North America Multiplex Detection Immunoassays Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Assay Type, 2018-2030
11.2.1. Planar Assays
11.2.1.1. Blends Protein Arrays (multiplexed ELISA)
11.2.1.2. Antibody Arrays
11.2.2. Bead-based Assays
11.2.2.1. Magnetic Bead-based
11.2.2.2. Non-magnetic Bead-based
11.3. Market Value Forecast, by Technique, 2018-2030
11.3.1. Nucleic Acid-based Techniques
11.3.2. Protein-based Techniques
11.3.3. Biosensor-based Techniques
11.4. Market Value Forecast, by Application, 2018-2030
11.4.1. Disease Testing
11.4.1.1. Infectious Disease Testing
11.4.1.2. Autoimmune Disease Testing
11.4.1.3. Other Diseases Testing
11.4.2. Food Contamination Testing
11.4.3. Research & Development
11.4.4. Veterinary Disease Testing
11.5. Market Value Forecast, by End-user, 2018-2030
11.5.1. Pharmaceutical & Biopharmaceutical Companies
11.5.2. Clinical Research Organizations
11.5.3. Food & Beverage Industry
11.5.4. Academic & Research Institutes
11.5.5. Diagnostic Centers
11.5.6. Others
11.6. Market Value Forecast, by Country, 2018-2030
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Assay Type
11.7.2. By Technique
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Multiplex Detection Immunoassays Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Assay Type, 2018-2030
12.2.1. Planar Assays
12.2.1.1. Blends Protein Arrays (multiplexed ELISA)
12.2.1.2. Antibody Arrays
12.2.2. Bead-based Assays
12.2.2.1. Magnetic Bead-based
12.2.2.2. Non-magnetic Bead-based
12.3. Market Value Forecast, by Technique, 2018-2030
12.3.1. Nucleic Acid-based Techniques
12.3.2. Protein-based Techniques
12.3.3. Biosensor-based Techniques
12.4. Market Value Forecast, by Application, 2018-2030
12.4.1. Disease Testing
12.4.1.1. Infectious Disease Testing
12.4.1.2. Autoimmune Disease Testing
12.4.1.3. Other Diseases Testing
12.4.2. Food Contamination Testing
12.4.3. Research & Development
12.4.4. Veterinary Disease Testing
12.5. Market Value Forecast, by End-user, 2018-2030
12.5.1. Pharmaceutical & Biopharmaceutical Companies
12.5.2. Clinical Research Organizations
12.5.3. Food & Beverage Industry
12.5.4. Academic & Research Institutes
12.5.5. Diagnostic Centers
12.5.6. Others
12.6. Market Value Forecast, by Country/Sub-region, 2018-2030
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Assay Type
12.7.2. By Technique
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Multiplex Detection Immunoassays Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Assay Type, 2018-2030
13.2.1. Planar Assays
13.2.1.1. Blends Protein Arrays (multiplexed ELISA)
13.2.1.2. Antibody Arrays
13.2.2. Bead-based Assays
13.2.2.1. Magnetic Bead-based
13.2.2.2. Non-magnetic Bead-based
13.3. Market Value Forecast, by Technique, 2018-2030
13.3.1. Nucleic Acid-based Techniques
13.3.2. Protein-based Techniques
13.3.3. Biosensor-based Techniques
13.4. Market Value Forecast By Application, 2018-2030
13.4.1. Disease Testing
13.4.1.1. Infectious Disease Testing
13.4.1.2. Autoimmune Disease Testing
13.4.1.3. Other Diseases Testing
13.4.2. Food Contamination Testing
13.4.3. Research & Development
13.4.4. Veterinary Disease Testing
13.5. Market Value Forecast, by End-user, 2018-2030
13.5.1. Pharmaceutical & Biopharmaceutical Companies
13.5.2. Clinical Research Organizations
13.5.3. Food & Beverage Industry
13.5.4. Academic & Research Institutes
13.5.5. Diagnostic Centers
13.5.6. Others
13.6. Market Value Forecast, by Country/Sub-region, 2018-2030
13.6.1. China
13.6.2. India
13.6.3. Japan
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia pacific
13.7. Market Attractiveness Analysis
13.7.1. By Assay Type
13.7.2. By Technique
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Multiplex Detection Immunoassays Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Assay Type, 2018-2030
14.2.1. Planar Assays
14.2.1.1. Blends Protein Arrays (multiplexed ELISA)
14.2.1.2. Antibody Arrays
14.2.2. Bead-based Assays
14.2.2.1. Magnetic Bead-based
14.2.2.2. Non-magnetic Bead-based
14.3. Market Value Forecast, by Technique, 2018-2030
14.3.1. Nucleic Acid-based Techniques
14.3.2. Protein-based Techniques
14.3.3. Biosensor-based Techniques
14.4. Market Value Forecast, by Application, 2018-2030
14.4.1. Disease Testing
14.4.1.1. Infectious Disease Testing
14.4.1.2. Autoimmune Disease Testing
14.4.1.3. Other Diseases Testing
14.4.2. Food Contamination Testing
14.4.3. Research & Development
14.4.4. Veterinary Disease Testing
14.5. Market Value Forecast, by End-user, 2018-2030
14.5.1. Pharmaceutical & Biopharmaceutical Companies
14.5.2. Clinical Research Organizations
14.5.3. Food & Beverage Industry
14.5.4. Academic & Research Institutes
14.5.5. Diagnostic Centers
14.5.6. Others
14.6. Market Value Forecast, by Country/Sub-region, 2018-2030
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Assay Type
14.7.2. By Technique
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Multiplex Detection Immunoassays Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Assay Type, 2018-2030
15.2.1. Planar Assays
15.2.1.1. Blends Protein Arrays (multiplexed ELISA)
15.2.1.2. Antibody Arrays
15.2.2. Bead-based Assays
15.2.2.1. Magnetic Bead-based
15.2.2.2. Non-magnetic Bead-based
15.3. Market Value Forecast, by Technique, 2018-2030
15.3.1. Nucleic Acid-based Techniques
15.3.2. Protein-based Techniques
15.3.3. Biosensor-based Techniques
15.4. Market Value Forecast, by Application, 2018-2030
15.4.1. Disease Testing
15.4.1.1. Infectious Disease Testing
15.4.1.2. Autoimmune Disease Testing
15.4.1.3. Other Diseases Testing
15.4.2. Food Contamination Testing
15.4.3. Research & Development
15.4.4. Veterinary Disease Testing
15.5. Market Value Forecast, by End-user, 2018-2030
15.5.1. Pharmaceutical & Biopharmaceutical Companies
15.5.2. Clinical Research Organizations
15.5.3. Food & Beverage Industry
15.5.4. Academic & Research Institutes
15.5.5. Diagnostic Centers
15.5.6. Others
15.6. Market Value Forecast, by Country/Sub-region, 2018-2030
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Assay Type
15.7.2. By Technique
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company, 2018
16.3. Company Profiles
16.3.1. F. Hoffmann-La Roche Ltd.
16.3.1.1. Company Overview
16.3.1.2. Company Financials
16.3.1.3. Growth Strategies
16.3.1.4. SWOT Analysis
16.3.2. QIAGEN
16.3.2.1. Company Overview
16.3.2.2. Company Financials
16.3.2.3. Growth Strategies
16.3.2.4. SWOT Analysis
16.3.3. Merck KGaA
16.3.3.1. Company Overview
16.3.3.2. Company Financials
16.3.3.3. Growth Strategies
16.3.3.4. SWOT Analysis
16.3.4. Microsynth AG
16.3.4.1. Company Overview
16.3.4.2. Company Financials
16.3.4.3. Growth Strategies
16.3.4.4. SWOT Analysis
16.3.5. Bio-Rad Laboratories
16.3.5.1. Company Overview
16.3.5.2. Company Financials
16.3.5.3. Growth Strategies
16.3.5.4. SWOT Analysis
16.3.6. Thermo Fisher Scientific
16.3.6.1. Company Overview
16.3.6.2. Company Financials
16.3.6.3. Growth Strategies
16.3.6.4. SWOT Analysis
16.3.7. Luminex Corporation
16.3.7.1. Company Overview
16.3.7.2. Company Financials
16.3.7.3. Growth Strategies
16.3.7.4. SWOT Analysis
16.3.8. Becton, Dickinson and Company
16.3.8.1. Company Overview
16.3.8.2. Company Financials
16.3.8.3. Growth Strategies
16.3.8.4. SWOT Analysis
16.3.9. Other Prominent Key Players
Note: Product cover images may vary from those shown
- F. Hoffmann-La Roche Ltd.
- QIAGEN
- Merck KGaA
- Microsynth AG
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Luminex Corporation
- Becton, Dickinson and Company
Note: Product cover images may vary from those shown
